Laboratory Markers of Endothelial Involvement in Rheumatic Diseases with Vasculitis in Childhood;Laboratorní Ukazatele Postižení Endotelu u Revmatických Onemocnění provázených vaskulitidou u dětí

Casopis Lekaru Ceskych

Volumn 142, Issue 10, 2003, Pages 615-619

  Doležalová, Pavla ^a   Telekesova P ^a   Nemcova D ^a   Belorova J ^a   Kvasnicka J ^a   Hoza, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Children; E selectin; Intercellular adhesion molecule 1; Rheumatic diseases; Von Willebrand factor

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ANAPHYLACTOID PURPURA; ARTICLE; BLOOD; BLOOD CELL COUNT; CELL ACTIVATION; CHILD; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE COUNT; PATHOGENESIS; RHEUMATIC DISEASE; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; VASCULITIS;

EID: 0142228709     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Pearson, J. D.: Normal endothelial cell function. Lupus 2000, 9, 183-188
2. Becker, B. F., Heindl, B., Kupatt, C., Zahler, S.: Endothelial function and hemostasis. Z. Kardiol., 89, 2000, s. 160-167.
3. Blann, A. D.: Von Willebrand factor as a marker of injury to the endothelium in iflammatory vascular disease. J. Rheumatol., 20, 1993, s. 1469-1470.
4. Kagawa, H., Okubo, S., Yasunaga, K.: Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and multimeric structure of von Willebrand factor (vWF). Int. J. Hematol., 54, 1991, s. 429-439.
5. Bleil, L., Manger, B., Winkler, T. H. et al.: The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis. J. Rheumatol., 18, 1991. s. 1199-1206.
6. Doria, A., Ghirardello, A., Boscaro, M. et al.: Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapy. Rheumatol. Int., 15, 1995, s. 207-211.
7. Direskeneli, H., Buchanan, N. M., et al.: Markers of vascular damage in lupus pregnancy. Clin. Exp. Rheumatol., 15, 1997, s. 535-539.
8. Ferro, D., Pittoni, V. et al.: Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state. Circulation, 18, 1997, s. 1425-1432.
9. Farrell, A. J., Williams, R. B., Stevens, C. R. et al.: Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis. Ann. Rheum. Dis., 51, 1992, s. 1117-1122.
10. Scheja, A., Eskilsson, J., Akesson, A., Wollheim, F. A.: Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosis. J. Rheumatol., 21, 1994, s. 639-642.
11. Herrick, A. L., Illingworth, K., Blann, A. et al.: Von Willebrand factor, thrombomodulin, thromboxane,_-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann. Rheum. Dis., 55, 1996, s. 122-127.
12. Cid, C. M.,Monteagudo, J., Oristrell, J. et al.: Von Willebrand factor in the outcome of temporal arteritis. Ann. Rheum. Dis., 55, 1996, s. 927-930.
13. Bowyer, S. L., Ragsdale, C. G., Sullivan, D. B.: Factor VIII related antigen and childhood rheumatic diseases. J. Rheumatol., 16, 1989, s. 1093-1097.
14. Nash, M. C., Shah, V., Dillon, M. J.: Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin. Exp. Immunol., 101, 1995, s. 13-17.
15. Blann, A. D., Dobrotova, M., Kubisz, P., McCollum, C. N.: Von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb. Haemost., 74, 1995, s. 626-630.
16. Lopes, A. A., Maeda, N. Y. et al.: Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension. Am. Heart. J., 139, 2000, s. 618-623.
17. Cronstein, B. N., Weissmann, G.: The adhesion molecules of inflammation. Arthritis Rheum., 36, 1993, s. 147-157.
18. Mojcik, C. F., Shevach, E. M.: Adhesion molecules: a rheumatologic perspective. Arthritis Rheum., 40, 1997, s. 991-1004.
19. Sfikakls, P. P., Mavrikakis, M.: Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseases. Clin. Rheumatol., 18, 1999, s. 317-327.
20. Bevilacqua, M. P., Nelson, R. M.: Selectins. J. Clin. Invest., 91, 1993, s. 379-387.
21. Pober, J. S., Cotran, R. S.: Cytokines and endothelial cell biology. Physiol. Rev., 70, 1990, s. 427-451
22. Gearing, A. J. H., Newman, W.: Circulating adhesion molecules in disease. Immunol. Today, 14, 1993, s. 506-512.
23. Haskard, D. O.: Lymphocyte traffic in inflammation. In: Oxford textbook of rheumatology, 2nd Ed, Oxford University Press 1998, s. 525-544.
24. Belmont, H. M., Buyon, J. et al.: Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Schwartzmann phenomenon revisited. Arthritis Rheum, 37, 1994, s. 376-383.
25. Egerer, K., Feist, E., Rohr, U. et al.: Increased soluble CD 14, ICAM-1 and E-selectin correlates with disease activity and prognosis in systemic lupus erythematosus. Lupus, 9, 2000, s. 614-621.
26. Ščudla, V., Horák, P., Lukeš, J. et al.: Sledování solubilních forem adhezivních molekul VCAM-1 aICAM-1 u nemocných se systémovým lupus erythematodes. Čs. Revmatol., 8, 2000, s. 119-126.
27. Denton, C. P., Bickerstaff, M. C. M., Shiwen, M. T. et al.: Seriál circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Brit. J. Rheumatol., 34, 1995, s. 1048-1054.
28. Veale, D. J., Kirk, G., McLaren, M., Belch, J. J. F.: Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis. Brit. J. Rheumatol., 37, 1998, s. 1227-1228.
29. Neumann Andersen, G., Caidahl, K., Kazzam, E. et al.: Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis. Findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule-1, and vascular adhesion molecule-1. Arthritis Rheum., 43, 2000, s. 1085-1093.
30. Kubo, M., Ihn, H., Yamane, K. et al: Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis. Brit. J. Dermatol., 143, 2000, s. 92-98.
31. Boehme, M. W. J., Raeth, U., Scherbaum, W. A. et al.: Interaction of endothelial cells and neutrophils in vitro: kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular cell adhesion molecule-1 (VCAM-1): implications for the relevance as serological disease activity markers in vasculitides. Clin. Exp. Immunol., 119, 2000, s. 250-254.
32. Stegeman, C. A., Cohen Tervaert, J. W. et al.: Serum levels of soluble adhesion molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with Wegener's granulomatosis. Arthritis Rheum, 37, 1994, s. 1228-1235.
33. Coll-Vinent, B., Grau, J. M., López-Soto, A. et al.: Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Brit. J. Rheumatol., 36, 1997, s. 1178-1183
34. Coll-Vinent, B., Vilardell, C., Font, C. et al.: Circulating soluble adhesion molecules in patients with giant cell arateritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity. Ann. Rheum. Dis., 58, 1999, s. 189-192.
35. Nassonov, E. L., Samsonov, M. Y., Chichasova, N. V. et al.: Soluble adhesion molecules in rheumatoid arthritis. Rheumatology, 39, 2000, s. 808-810.
36. Bloom, B. J., Miller, L. C., Tucker, L. B. et al.: Soluble adhesion molecules in juvenile rheumatoid arthritis. J. Rheumatol., 26, 1999, s. 2044-2048.
37. De Benedetti, F., Vivarelli, M., Pignatti, P. et al.: Circulating levels of soluble E.selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. J. Rheumatol., 27, 2000, s. 2246-2250.
38. Kim, D. S., Lee, K. Y.: Serum soluble E-selectin levels in Kawasaki disease. Scand. J. Rheumatol., 23, 1994, s. 283-286.
39. Doležalová, P., Telekešová, P., Němcová, D., Hoza, J.: Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis - clinical and laboratory correlations. Clin. Exp. Rheumatol., 20, 2002, s. 249-254.
40. Elhadd, T. A., Kennedy, G. et al.: Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab. Res. Rev., 15, 1999, s. 405-411.
41. Lupatelli, G., Lombardini, R. et al.: Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: Association with small, dense LDL cholesterol particles. Am. Heart. J., 140, 2000, s. 521-526.
42. Lei, K. I. K., Johnson, P. J.: The prognostic significance of serum levels of soluble intercellular adhesion-1 in patients with primary extranodal non-Hodgkin lymphomas. Cancer, 89, 2000, s. 1387-1395.
43. Lai, N. K., Leung, J. C. K., Lai, K. B. et al.: Increased release of von Willebrand factor antigen from endothelial cells by anti-DNA antibodies. Ann. Rheum. Dis., 55, 1996, s. 57-62.
44. Blann, A. D., Herrick, A., Jayson, M. I. V.: Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Brit. J. Rheumatol., 34, 1995, s. 814-819.
45. Bloom, B. J., Tucker, L. B., Miller, L. C., Schaller, J.: Von Willebrand factor in juvenile dermatomyositis. J. Rheumatol., 22, 1995, s. 320-325.
46. Pachman, L. M.: Imperfect indications of disease activity in juvenile dermatomyositis. J. Rheumatol., 22, 1995, s. 193-197.
47. Furukawa, S., Imai, K., Matsubara, T. et al.: Increased levels of circulating adhesion molecule 1 in Kawasaki disease. Arthritis Rheum., 35, 1992, s. 672-677.
48. Gattorno, M., Vignola, Barbano, G. et al.: Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus. J. Rheumatol., 27, 2000, s. 2251-2255.
49. Andrýs, C., Pozler, O., Krejsek, J. et al.: Serum soluble adhesion molecules (sICAM-1, sVCAM-1 and SE-selectin) in healthy school aged children and adults. Acta medica (Hradec Králové), 43, 2000, s. 103-106.